A team at Carnegie Mellon University introduced 'AggreBots,' microscale living robots fabricated from human lung cells capable of customizable motility. Published in Science Advances, this tissue engineering platform enables precise control over robot movement patterns, paving the way for future in vivo delivery of therapeutics or interventions. These biohybrid devices represent a pioneering fusion of biology and robotics with potential biomedical applications.